from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1908c/katG

LFCtreatmentdescriptionclass of inhibitor

-0.917

Amikacinug/mL Amikacintranslation

-1.506

Cap5-10ug/mL Capreomycintranslation

-1.106

Rox10-50 ug/mL Roxithromycintranslation

1.023

SM2-5 ug/mL Streptomycintranslation

-1.160

Tet5-10 ug/mL Tetracyclinetranslation

-0.567

Rif0.2-5ug/mL Rifampicintranscription

-0.991

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.007

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.849

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.279

CPZ10-50 ug/mL Chlorpromazinerespiration

1.870

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.605

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

2.056

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.484

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

2.098

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.755

Econazole10-24 ug/mL Econazole (azole drug)respiration

1.430

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.423

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

2.450

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

2.453

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

3.357

KCN5-20 ug/mL Potassium cyaniderespiration

0.067

NaN30.2-2 mM Sodium aziderespiration

0.099

Nigericin50 uM Nigericinrespiration

0.427

TRC10-150 ug/mL Triclosanrespiration

-0.485

TRZ10-25 ug/mL Thioridazinerespiration

-1.483

Valinomycin0.5-10 uM Valinomycinrespiration

-0.824

ZnSO42 mM ZnSO4respiration

2.121

menadione6-10 ug/mL Menadionerespiration

-1.945

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.892

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-1.141

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.527

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.745

NRP_1Non-replicating persistence stage 1dosRassociated

-0.385

Amp0.2mg/mL AmpicillincellWall

-0.250

Cephalexin20-100 ug/mL CephalexincellWall

-0.586

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.460

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.470

EMB10-20 ug/mL EthambutolcellWall

-0.493

Eta12-40 ug/mL EthionamidecellWall

-0.514

INH0.2-0.4 ug/mL IsoniazidcellWall

0.040

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.451

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.706

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.721

BZA0.12 mg/mL BenzamidearomaticAmides

0.455

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.047

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.548

H2O24 mM hydrogen peroxideDNAdamaging

-0.653

Levo10 ug/mL LevofloxacinDNAdamaging

0.082

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.410

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.383

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.061

UVUV-irradiationDNAdamaging

1.879

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.357

Antimycin12.5-50 ug/mL Antimycin A?

-0.358

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

2.051

PA_110-50 ug/mL Antitubercular compound PA-1?

0.682

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.318

PA8240.2-2 ug/mL PA-824?

-0.361

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.067

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.351

Verapamil50 uM Verapamil?

0.988

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.151

methoxatin10-20 ug/mL Methoxatin?